Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1077)	1/3/2001 8:39:23 AM
From: Bosco	Read Replies (1) of 1298

Hi tuck - thanks. I saw it in Yahoo! too. However, I am surprised there is a lengthy article in The Boston Globe boston.com in its The Nation section. I'd think Massachusetts is one of the top tier biotech enclaves and this exposure is significant. I mean, it may be reasonable for the site to cover local celeb like Dr Fokeman [sp?] of the Angiostatin fame. However, coverage of CEGE, an out of state biotech, somehow shows news worthiness. Besides, Phase I was done at John Hopkins, another out of state institution. So, I think GVAX should catch some people's eyes best, Bosco

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next